PDMR DEALING NOTIFICATION
|
1 |
Details of the person discharging managerial responsibilities/person closely associated |
|||||||||
|
a) |
Name |
Robert Langer |
||||||||
|
2 |
Reason for the notification |
|||||||||
|
a) |
Position/status |
Director |
||||||||
|
b) |
Initial notification/Amendment |
Initial notification |
||||||||
|
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|||||||||
|
a) |
Name |
PureTech Health plc |
||||||||
|
b) |
LEI |
213800LVPDNO2Z9T9I39 |
||||||||
|
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|||||||||
|
a) |
Description of the financial instrument, type of instrument Identification code |
|
||||||||
|
b) |
Nature of the transaction |
A transfer of Ordinary Shares for nil consideration from Robert Langer to the Langer Family 2020 Trust. |
||||||||
|
c) |
Price(s) and volume(s) |
|
||||||||
|
d) |
Aggregated information
|
|
||||||||
|
e) |
Date of the transaction |
17 December 2020 |
||||||||
|
f) |
Place of the transaction |
Outside of a trading venue |
||||||||
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
